Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study

被引：0
|
作者：
Constant V. M. Verschuur
S. R. Suwijn
B. Post
M. Dijkgraaf
B. R. Bloem
J. J. van Hilten
T. van Laar
G. Tissingh
G. Deuschl
A. E. Lang
R. J. de Haan
R. M. A. de Bie
机构：
[1] University of Amsterdam,Department of Neurology, Academic Medical Center
[2] Radboud University Medical Center,Department of Neurology, Donders Institute for Brain, Cognition and Behavior
[3] Clinical Research Unit,Academic Medical Center
[4] Leiden University Medical Center,Department of Neurology
[5] University Medical Center Groningen,Department of Neurology
[6] Atrium-Orbis Medical Center Heerlen/Sittard,Department of Neurology
[7] University Medical Center Schleswig-Holstein,Department of Neurology
[8] University of Toronto,The Edmond J. Safra Program in Parkinson’s Disease and Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital
来源：
BMC Neurology | / 15卷
关键词：
Parkinson’s disease; Levodopa; Randomised delayed-start placebo-controlled trial; Disease modifying;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson's disease
    Chong, K. K.
    Lim, S. Y.
    Manap, M. A. A. A.
    Lim, J. L.
    Low, S. C.
    Mahadeva, S. K.
    Tan, A. H.
    MOVEMENT DISORDERS, 2018, 33 : S194 - S194
  • [42] A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Dyskinesia in Parkinson's Disease
    Wong, Kitty K.
    Alty, Jane E.
    Goy, Amanda G.
    Raghav, Sanjay
    Reutens, David C.
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1552 - 1555
  • [43] Sarizotan as a treatment for dyskinesias in Parkinson's disease:: A double-blind placebo-controlled trial
    Goetz, Christopher G.
    Damier, Philippe
    Hicking, Christine
    Laska, Eugene
    Mueller, Thomas
    Olanow, C. Warren
    Rascol, Olivier
    Russ, Hermann
    MOVEMENT DISORDERS, 2007, 22 (02) : 179 - 186
  • [44] Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
    Aisen, Paul S.
    Gauthier, Serge
    Ferris, Steven H.
    Saumier, Daniel
    Haine, Denis
    Garceau, Denis
    Anh Duong
    Suhy, Joyce
    Oh, Joonmi
    Lau, Wan C.
    Sampalis, John
    ARCHIVES OF MEDICAL SCIENCE, 2011, 7 (01) : 102 - 111
  • [45] Metformin for knee osteoarthritis with obesity: study protocol for a randomised, double-blind, placebo-controlled trial
    Lim, Yuan Z.
    Wang, Yuanyuan
    Urquhart, Donna M.
    Estee, Mahnuma Mahfuz
    Wluka, Anita E.
    Heritier, Stephane
    Cicuttini, Flavia M.
    BMJ OPEN, 2023, 13 (12):
  • [46] Metformin for low back pain: Study protocol for a randomised, double-blind, placebo-controlled trial
    Lim, Yuan Z.
    Urquhart, Donna M.
    Wang, Yuanyuan
    Estee, Mahnuma Mahfuz
    Wluka, Anita E.
    Heritier, Stephane
    Cicuttini, Flavia M.
    OSTEOARTHRITIS AND CARTILAGE OPEN, 2025, 7 (01):
  • [47] A double-blind, randomised, placebo-controlled trial to investigate the efficacy and safety of nebicapone in levodopa-treated Parkinson's disease patients with motor fluctuations
    Ferreira, J. J.
    Rascol, O.
    Poewe, W.
    Sampaio, C.
    Rocha, F.
    Nunes, T.
    Almeida, L.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2008, 23 (01) : S195 - S195
  • [48] Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Mcgarry, Andrew
    Rosanbalm, Shane
    Leinonen, Mika
    Olanow, Warren
    To, Dennis
    Bell, Adam
    Lee, Daniel
    Chang, Jamie
    Dubow, Jordan
    Dhall, Rohit
    Burdick, Daniel
    Parashos, Sotirios
    Feuerstein, Jeanne
    Quinn, Joseph
    Pahwa, Rajesh
    Afshari, Mitra
    Ramirez-Zamora, Aldolfo
    Chou, Kelvin
    Tarakad, Arjun
    Luca, Corneliu
    Klos, Kevin
    Bordelon, Yvette
    St Hiliare, Marie-Helene
    Shprecher, David
    Lee, Seulki
    Dawson, Ted M.
    Roschke, Viktor
    Kieburtz, Karl
    LANCET NEUROLOGY, 2024, 23 (01): : 37 - 45
  • [49] Alzheimer's Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial
    Chen, Christopher L. H.
    Lu, Qingshu
    Moorakonda, Rajesh Babu
    Kandiah, Nagaendran
    Tan, Boon Yeow
    Villaraza, Steven Gayoles
    Cano, Jemelle
    Venketasubramanian, Narayanaswamy
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2022, 23 (03) : 379 - +
  • [50] IV DROPERIDOL OR OLANZAPINE AS ADJUNCTS TO MIDAZOLAM FOR THE ACUTELY AGITATED PATIENT: A MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL TRIAL
    Chan, Esther
    Taylor, David Mcd
    Kong, David
    Knott, Jonathan
    Phillips, Georgina
    Castle, David
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S259 - S259
12345